Applied Clinical Trials Online2d
Leveraging Technology for Efficient Trial Design
Teams must work together with technology solutions and optimize integration to unlock their full potential. Clinical trials ...
Applied Clinical Trials Online3d
Ensuring the Long-Term Effectiveness of Clinical Trials
In this video interview, Iddo Peleg, CEO and co-founder at Yonalink, talks innovation in clinical technology and how the FDA can continue to promote its adoption.
Applied Clinical Trials Online3d
Investigational Pain Therapy Cebranopadol Succeeds in Second Phase III Clinical Trial
Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...
Applied Clinical Trials Online4d
Opportunities Amidst Recent Research Policy Challenges
In this video interview, Iddo Peleg, CEO and co-founder at Yonalink, discusses the need for change in the clinical research ...
appliedclinicaltrialsonline4d
Phase III Trials Confirm Remibrutinib Effectively Reduces Chronic Spontaneous Urticaria Symptoms
Phase III REMIX-1 and REMIX-2 trials demonstrated that remibrutinib, an oral BTK inhibitor, significantly reduced chronic spontaneous urticaria symptoms in patients unresponsive to second-generation ...
Applied Clinical Trials Online5d
Increasing Clinical Trial Diversity with a Satellite Model
In this video interview, Iddo Peleg, CEO and co-founder at Yonalink, highlights the need for a satellite model in bringing ...
Applied Clinical Trials Online5d
Legal and Political Implications of the NIH Funding Freeze
Ron Lanton, Partner, Lanton Law, shares his insights on the legal and political consequences of the NIH funding freeze and potential options for continuing research.
appliedclinicaltrialsonline5d
Analysis of KEYNOTE-A18 Trial Finds Keytruda is Not Cost-Effective at Current Prices
Analysis shows the addition of Keytruda (pembrolizumab) to standard chemoradiotherapy for newly diagnosed, locally advanced cervical cancer is not cost-effective at its current price. A ...